Pharmaceutical Industry Information Portal

HomeNews

News

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Following closing of the acquisition, Bayer will own full rights to Vividion’s proprietary discovery platform, which comprises three integrated, synergistic components.

Petrovax to manufacture up to 10 mln doses of China’s Convidencia a month

The company said earlier that it planned to commission its Convidencia full cycle production line by the end of 2021.

Combination of the Sputnik Light with others vaccines demonstrates high safety profile

Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.

EC approves contract for a potential COVID-19 vaccine with Novavax

Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses.

Laboratorios Richmond to provide with over 3 million doses of the second component of the Sputnik V vaccine

RDIF and partners facilitated the technology transfer to Laboratorios Richmond for the local production of the vaccine with the first batch manufactured in April 2021.

Antitrust watchdog sets maximum selling price for 50 doses of CoviVac vaccine at $297

FAS has agreed on the maximum selling price for a new package of the CoviVac vaccine. The new form of vaccine release contains 50 doses.
spot_img

Expert Articles

spot_img